Have originator medicines’ list prices started to drop in the US?
According to the GlobalData service Price Intelligence (POLI) & HTA, more than 800 originator molecules still posted price hikes to their WACs and AWPs.
Comment & Opinion
The beginning of the end: Eliquis sales forecast to plummet as EU patent expiry nears
The new safety mandate driving AI-ready pharmacovigilance
When trillion‑member libraries meet physics: what diversity really means
UK–US zero‑tariff deal pricing reforms position UK as global hub for new medicines
JPM26: Immunocore Signals Entry into type 1 diabetes
JPM26: Atea Pharmaceuticals outlines HCV strategy centred on short-duration regimens
Transformative arrival of oral weight loss medicines in the US
